Treatment of an acute attack of type III hereditary angioedema with ecallantide

Ann Allergy Asthma Immunol. 2012 Jan;108(1):61-62. doi: 10.1016/j.anai.2011.09.020. Epub 2011 Nov 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Disease
  • Adolescent
  • Hereditary Angioedema Type III / drug therapy*
  • Humans
  • Kallikreins / antagonists & inhibitors*
  • Male
  • Peptides / therapeutic use*
  • Treatment Outcome

Substances

  • Peptides
  • ecallantide
  • Kallikreins